SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 76 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,757,583 | +77.3% | 9,459,678 | +214.3% | 0.70% | +84.8% |
| Q2 2023 | $20,164,843 | +2.9% | 3,009,678 | 0.0% | 0.38% | -14.2% |
| Q1 2023 | $19,593,004 | -23.7% | 3,009,678 | 0.0% | 0.44% | -14.8% |
| Q4 2022 | $25,672,553 | +121.3% | 3,009,678 | +72.8% | 0.52% | +154.1% |
| Q4 2021 | $11,603,000 | -33.3% | 1,742,186 | 0.0% | 0.20% | -14.9% |
| Q3 2021 | $17,387,000 | -67.7% | 1,742,186 | 0.0% | 0.24% | -72.1% |
| Q2 2021 | $53,816,000 | -29.2% | 1,742,186 | 0.0% | 0.86% | -24.6% |
| Q1 2021 | $76,012,000 | -5.8% | 1,742,186 | 0.0% | 1.15% | +1.5% |
| Q4 2020 | $80,733,000 | – | 1,742,186 | – | 1.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 4,012,903 | $15,168,773 | 7.77% |
| Nextech Invest Ltd. | 1,910,029 | $7,219,910 | 2.19% |
| K2 PRINCIPAL FUND, L.P. | 2,552,062 | $9,646,794 | 2.02% |
| Charles Schwab Trust Co | 4,246,071 | $16,050,148 | 1.81% |
| Sio Capital Management, LLC | 1,105,911 | $4,180,344 | 1.29% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,077,927 | $41,874,564 | 0.92% |
| SECTORAL ASSET MANAGEMENT INC | 1,049,191 | $3,965,942 | 0.77% |
| Orbimed Advisors | 9,240,887 | $34,930,553 | 0.74% |
| RA Capital Management | 9,459,678 | $35,757,583 | 0.70% |
| K2 PRINCIPAL FUND, L.P. | 688,900 | $2,604,042 | 0.55% |